The global guidewires market size is estimated to reach USD 4.43 billion by 2033, expanding at a CAGR of 5.53% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market is expected to grow during the forecast period due to various factors such as the increasing number of minimally invasive surgeries, increasing prevalence of chronic diseases, and the rising geriatric population. For instance, in November 2022, the ‘Administration on Aging’ report projected that the number of people aged 65 and older will rise to 95 million by 2060 in the U.S.
Cardiovascular diseases such as coronary artery disease and peripheral arterial disease, pose significant challenges to global health. Guidewires are indispensable tools used in the diagnosis and treatment of these conditions, allowing physicians to navigate through complex networks of blood vessels and precisely deliver therapies. With the increasing incidence and prevalence of cardiovascular diseases, there is a growing need for guidewires, contributing to market expansion. For instance, in January 2022, The American Heart Association (AHA) projected that there will be more than 23.6 million cases of cardiovascular disease worldwide in 2030.
Additionally, product developments, adaptations, and marketing initiatives stimulate future increases in product demand. The major players have also adopted fresh tactics for their improvement. For instance, in June 2022, Cardio Flow, Inc., received FDA clearance for FreedomFlow Peripheral Guidewire, which was created to offer exceptional support. This device offers support for diagnostic and therapeutic devices used in treating Atherosclerosis, both above and below the knee. Thus, the growing adoption of technological advancement by various organizations is anticipated to upsurge the guidewire industry from 2023 to 2030.
Request a free sample copy or view report summary: Guidewires Market Report
By product, coronary guidewires accounted for the largest market share of 42.93% in 2025, owing to the high demand for minimally invasive coronary surgery. An increasing number of hospitalizations of atherosclerosis patients and the rising prevalence of cardiovascular disease also contribute to the segment growth
The North American region held the largest revenue share of 34.80% in 2025 owing to various factors, such as the growing number of heart diseases and the presence of major players in the market
The Europe guidewires market held a significant share in 2025 due to increasing production of guidewires in the region. Factors that can be attributed to growth include the rising geriatric population, increasing number of surgeries, and rising expenditure on healthcare
The market is highly competitive with the presence of players including Boston Scientific Corporation, BD, Abbott, Medtronic, Cook, Merit Medical Systems, Stryker, B. Braun, and ConMed Corporation
Grand View Research has segmented the global guidewires market based on product, and region:
Guidewires Product Outlook (Revenue, USD Million, 2021 - 2033)
Coronary Guidewires
Peripheral Guidewires
Urology Guidewires
Neurovascular Guidewires
Guidewires Region Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Guidewires Market
Boston Scientific Corporation
Abbott
Cordis (Cardinal Health)
AngioDynamics
Medtronic
Stryker
Cook
BD
Codman Neuro (Integer Holdings Corporation)
Terumo Medical Corporation
Merit Medical Systems
Olympus Corporation
Teleflex Incorporated
B. Braun
Asahi Intecc Co., Ltd.
ConMed Corporation
Argon Medical Devices
SP Medical A/S
TE Connectivity (formerly Creganna Medical)
Galt Medical Corp
Balton
Manish Medi Innovation
ST. Stone Medical Devices Private Limited
Custom Wire Technologies, Inc.
ACE Medical Devices
BrosMed Medical Co., Ltd.
Cathwide Medical Co. Ltd.
Creo Medical
Foshan Dihua Technology Co., Ltd.
"The quality of research they have done for us has been excellent..."